Sacubitril/valsartan study for high blood pressure by body size
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests how sacubitril/valsartan may affect heart function in people with high blood pressure, and whether results differ by body size (BMI). You may benefit by getting closer heart monitoring, though it depends on whether you fit the safety and medical criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have essential (primary) high blood pressure
- You are between 18 and 70 years old
- You can read, understand, and sign the consent form
- Your high blood pressure is not from another cause (secondary hypertension), except sleep apnea
- You have not had a heart attack, heart failure, stroke, or heart procedure in the last 6 months
- You do not have severe other illnesses that could interfere with the study (like active cancer or severe lung, liver, or digestive disease) and you can follow study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication can help control blood pressure and support weight management in people with overweight and high blood pressure. It may offer a new option for improving heart health.
This trial tests whether a combination of two blood pressure drugs (sacubitril/valsartan) is better than one drug alone (valsartan) at improving heart function in people with high blood pressure. It may help reduce strain on the heart's upper chambers.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This trial tests a drug called sacubitril/valsartan to see if it helps people who have both a prosthetic heart valve and heart failure with a weak heart pump. The goal is to improve heart function and symptoms.
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.
Hear when a new Sacubitril/Valsartan trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.